Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...
Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...
The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...
The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...
Princess Kate Middleton honored late cancer patient Liz Hatton, whom the royal first met in October last year. “Celebrating ...
Get matched with a Pet Insurance partner. If you’re like most pet owners, your dog or cat is part of the family, and you want ...
Narayana Hrudayalaya jumped 2.01% to Rs 1597.55 after the firm's foreign subsidiary, Health City Cayman Islands(HCCI) entered into a joint venture (JV) agreement with 2070 Health Inc., W Health ...
REHOVOT, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: ...
MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...
A recent study shows that breast cancer survivors who undergo chemotherapy face prolonged physical decline, including fatigue ...
NIH clinical trials are a lifeline for cancer patients like Baltimore native Vanessa, who received a groundbreaking immunotherapy treatment at the Kimmel Cancer Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback